These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 37452431)

  • 21. MiR-155: An Important Regulator of Neuroinflammation.
    Zingale VD; Gugliandolo A; Mazzon E
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human microRNA (miR-20b-5p) modulates Alzheimer's disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer's biomarkers.
    Wang R; Chopra N; Nho K; Maloney B; Obukhov AG; Nelson PT; Counts SE; Lahiri DK
    Mol Psychiatry; 2022 Feb; 27(2):1256-1273. PubMed ID: 35087196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research progress on lncRNAs in Alzheimer's disease.
    Xiong WD; Xu KY; Lu L; Li JL
    Yi Chuan; 2022 Mar; 44(3):189-197. PubMed ID: 35307642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-15b reduces amyloid-β accumulation in SH-SY5Y cell line through targetting NF-κB signaling and BACE1.
    Li J; Wang H
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29961672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology.
    Sarkar S; Engler-Chiurazzi EB; Cavendish JZ; Povroznik JM; Russell AE; Quintana DD; Mathers PH; Simpkins JW
    Brain Res; 2019 Oct; 1721():146327. PubMed ID: 31295467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating miRNAs as potential biomarkers in Alzheimer's disease.
    Galimberti D; Villa C; Fenoglio C; Serpente M; Ghezzi L; Cioffi SM; Arighi A; Fumagalli G; Scarpini E
    J Alzheimers Dis; 2014; 42(4):1261-7. PubMed ID: 25024331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
    Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
    Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
    Zhang J; Wang R
    Exp Gerontol; 2021 Feb; 144():111180. PubMed ID: 33279663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments.
    Seyedaghamiri F; Rajabi M; Mohaddes G
    Neurochem Res; 2023 Jan; 48(1):26-38. PubMed ID: 36048350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hidden players: Shedding light on the significance of post-translational modifications and miRNAs in Alzheimer's disease development.
    Singh R; Hussain J; Kaur A; Jamdare BG; Pathak D; Garg K; Kaur R; Shankar S; Sunkaria A
    Ageing Res Rev; 2023 Sep; 90():102002. PubMed ID: 37423542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review.
    Millan MJ
    Prog Neurobiol; 2017 Sep; 156():1-68. PubMed ID: 28322921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease.
    Elzayat EM; Shahien SA; El-Sherif AA; Hosney M
    J Alzheimers Dis; 2023; 94(s1):S203-S225. PubMed ID: 37212107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of miR-26a-5p Suppresses Tau Phosphorylation and Aβ Accumulation in the Alzheimer's Disease Mice by Targeting DYRK1A.
    Liu Y; Wang L; Xie F; Wang X; Hou Y; Wang X; Liu J
    Curr Neurovasc Res; 2020; 17(3):241-248. PubMed ID: 32286945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
    Dehghani R; Rahmani F; Rezaei N
    Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulated Blood miR-150-5p in Alzheimer's Disease Dementia Is Associated with Cognition, Cerebrospinal Fluid Amyloid-β, and Cerebral Atrophy.
    Chia SY; Vipin A; Ng KP; Tu H; Bommakanti A; Wang BZ; Tan YJ; Zailan FZ; Ng ASL; Ling SC; Okamura K; Tan EK; Kandiah N; Zeng L
    J Alzheimers Dis; 2022; 88(4):1567-1584. PubMed ID: 35811521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-124 regulates cerebromicrovascular function in APP/PS1 transgenic mice via C1ql3.
    Li AD; Tong L; Xu N; Ye Y; Nie PY; Wang ZY; Ji LL
    Brain Res Bull; 2019 Nov; 153():214-222. PubMed ID: 31499089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of miRNAs in Alzheimer's Disease and Possible Fields of Application.
    Silvestro S; Bramanti P; Mazzon E
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31443326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Potential Role of miRNA-Regulated Autophagy in Alzheimer's Disease.
    Zhang H; Liang J; Chen N
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer's Disease.
    Wang L; Shui X; Diao Y; Chen D; Zhou Y; Lee TH
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo.
    Yang G; Song Y; Zhou X; Deng Y; Liu T; Weng G; Yu D; Pan S
    Mol Med Rep; 2015 Aug; 12(2):3081-8. PubMed ID: 25955795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.